SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9475	Companies
185442	Keywords
117783	Articles
99298	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 08/11/2025 at 18:30, 3 months 24 days ago

Sanofi: Disclosure of trading in own shares
BRIEF

published on 08/06/2025 at 07:05, 3 months 30 days ago

Sanofi Finalizes Acquisition of Vigil Neuroscience

Acquisition Sanofi Neurology Vigil Neuroscience VG-3927
PRESS RELEASE

published on 08/06/2025 at 07:00, 3 months 30 days ago

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
Sanofi announces completion of Vigil Neuroscience, Inc. acquisition, reinforcing neurology pipeline with VG-3927 for Alzheimer's. Vigil shareholders receive CVR. VGL101 not acquired

Acquisition Sanofi Neurology Alzheimer's Vigil Neuroscience
BRIEF

published on 07/22/2025 at 07:35, 4 months 14 days ago

Sanofi acquires Vicebio to boost its respiratory vaccine portfolio

Sanofi Acquisition Vicebio Respiratory Vaccines Molecular Clamp Technology Biotechnology Investment
PRESS RELEASE

published on 07/22/2025 at 07:30, 4 months 14 days ago

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
Sanofi acquires Vicebio, enhancing respiratory vaccines pipeline with 'Molecular Clamp' technology and combination vaccine candidates for RSV and hMPV, expanding capabilities in vaccine development

Sanofi Vicebio Respiratory Vaccines Molecular Clamp Technology Combination Vaccines
BRIEF

published on 07/18/2025 at 07:05, 4 months 18 days ago

Sanofi Completes Acquisition of Blueprint Medicines

Acquisition Sanofi Blueprint Medicines Systemic Mastocytosis Ayvakit
PRESS RELEASE

published on 07/18/2025 at 07:00, 4 months 18 days ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
BRIEF

published on 07/16/2025 at 07:05, 4 months 20 days ago

Sanofi: Fast track designation for SAR446597 in the United States

FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE

published on 07/16/2025 at 07:00, 4 months 20 days ago

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy

Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE

published on 07/15/2025 at 18:30, 4 months 20 days ago

Sanofi: Disclosure of trading in own shares

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 8 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 13 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 43 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 38 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 43 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 28 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 1 hour 13 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 27 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 2 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 13 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 58 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 43 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 58 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 58 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE